We’ve arranged a terrific Innovations in Psychiatry Symposium at Mount Sinai entitled Advances in Understanding and Treating Psychotic Disorders. Dr. Rene Kahn is Chair, and I’m Co-chair. The meeting is February 17 in Goldwurm Auditorium at our Icahn School of Medicine. Among other leaders, Eric J. Nestler, MD, PhD, Sophia Frangou, MD, PhD, Pamela Sklar, MD, PhD, and René S. Kahn, MD, PhD will be speaking. See below for details.
Please let the IP roster know. We can discount or even comp them.
The Department of Psychiatry at Mount Sinai invites you to attend our 5th Annual Innovations in Psychiatry Symposium: Advances in Understanding and Treating Psychotic Disorders
We hope you can join us at the 5th Annual Innovations in Psychiatry Symposium, held in Goldwurm Auditorium at the Icahn School of Medicine at Mount Sinai on Friday, February 17, 2017.
The program, entitled Advances in Understanding and Treating Psychotic Disorders, will feature presentations from leading experts including
Eric J. Nestler, MD, PhD, Sophia Frangou, MD, PhD, Pamela Sklar, MD, PhD, and René S. Kahn, MD, PhD, as well as other distinguished experts including Bita Moghaddam, PhD, Chair and Ruth Matarazzo Professor of Behavioral Neuroscience at Oregon Health & Science University, Godfrey Pearlson, MD, Professor of Psychiatry and Neurobiology at Yale University School of Medicine, and Romina Mizrahi, MD, PhD, Associate Professor in Psychiatry at University of Toronto.
Dr. Kahn, an internationally renowned expert on the neurobiology of schizophrenia and other psychotic disorders, was appointed Chair of the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai on January 1, 2017.
The symposium is part of a broader initiative from the Department of Psychiatry and the Mount Sinai Health System to bring to bear basic discoveries in neuroscience, to better understand the causes of major psychiatric disorders, and to develop innovative treatments.
The Department of Psychiatry would like to thank Karen Davis, PhD, and the Deborah Elkins Foundation for supporting the Symposium, as well as Sophia Frangou, MD, PhD, and Ahron Friedberg, MD, for organizing the event.
The Department encourages participants to register before the Symposium. The fees are as follows:
$125 – Physicians and Health Professionals
No fee – Mount Sinai Health System Faculty, Staff, and Voluntary Faculty
No fee – All Residents and Fellows in Training
A fee of $25 applies to processing on-site registrants
Register online at www.mssm.edu/cme/courses. For more information, please e-mail the Office of CME at cme@mssm.edu or call 212-731-7950.
Schedule of Events: Friday, February 17, 2017
8:00-8:30 am
Registration
8:30-8:45 am
Opening remarks: Eric J. Nestler, MD, PhD
8:45-9:30 am
Keynote #1: On the origins of psychiatric illness – with an emphasis on schizophrenia
René S. Kahn, MD, PhD
9:30-9:40 am
Break
Panel 1: Translational research for the treatment of psychotic disorders
(9:40-12:00 pm)
Moderator: Joseph D. Buxbaum, PhD
9:40-10:10 am
Schizophrenia and the genome in 3D
Schahram Akbarian, MD, PhD
10:10-10:40 am
Genetic complexity in schizophrenia
Pamela Sklar, MD, PhD
10:40-11:10 am
A novel role for dopamine regulation of information processing: relevance of psychosis
Bita Moghaddam, PhD
11:10-11:40 am
Panel discussion and Q&A
12:00-1:00 pm
Lunch
1:00-1:45 pm
Keynote #2: Linking mind and brain in psychosis
Sophia Frangou, MD, PhD
1:45-2:00 pm
Break
Panel 2: Innovative treatments for psychotic disorders (2:00-3:30 pm)
Moderator: Ahron Friedberg, MD
2:00-2:30 pm
Neuroinflammation in psychosis and youths at risk
Romina Mizrahi, MD, PhD
2:30-3:00 pm
Biotypes in psychosis
Godfrey Pearlson, MD
3:00-3:30 pm
Predicting psychosis in general population
Avraham Reichenberg, PhD
3:30-4:00 pm
Panel discussion and Q&A
4:00-4:15 pm
Concluding remarks: René S. Kahn, MD, PhD
Symposium Faculty
Planning Committee/Course Directors
Program Director
René S. Kahn, MD, PhD, Professor and Chair, Department of Psychiatry; Icahn School of Medicine at Mount Sinai
Program Co-Directors
Sophia Frangou, MD, PhD, Professor, Department of Psychiatry; Icahn School of Medicine at Mount Sinai
Ahron Friedberg, MD,Clinical Professor, Department of Psychiatry; Icahn School of Medicine at Mount Sinai
Guest Faculty
Romina Mizrahi, MD, PhD, Director, Focus on Youth Psychosis Prevention Clinic Centre for Addiction and Mental Health; Associate Professor in Psychiatry, University of Toronto
Bita Moghaddam, PhD, Chair and Ruth Matarazzo Professor of Behavioral Neuroscience; Oregon Health & Science University
Godfrey Pearlson, MD, Professor, Psychiatry and Neurobiology, Yale University School of Medicine; Director, Olin Neuropsychiatry Research Center, Institute of Living, HHC
Icahn School of Medicine at Mount Sinai Faculty
Schahram Akbarian, MD, PhD, Professor of Psychiatry & Neuroscience; Icahn School of Medicine at Mount Sinai
Joseph D. Buxbaum, PhD, Deputy Chair and Vice Chair for Research
Department of Psychiatry; Director, Seaver Autism Center for Research and Treatment; Professor of Psychiatry, Neuroscience and Genetics and Genomic Sciences; Icahn School of Medicine at Mount Sinai
Eric J. Nestler, MD, PhD, Dean for Academic and Scientific Affairs; Director, Friedman Brain Institute; Professor, Neuroscience, Pharmacological Sciences & Psychiatry; Icahn School of Medicine at Mount Sinai
Avraham Reichenberg, PhD, Professor of Psychiatry & Environmental Medicine & Public Health; Icahn School of Medicine at Mount Sinai
Pamela Sklar, MD, PhD, Chief of the Division of Psychiatric Genomics; Professor of Psychiatry, Neuroscience, Genetics and Genomic Sciences; Icahn School of Medicine at Mount Sinai
Learning Objectives
At the conclusion of the activity, participants will be able to:
1. Identify the genetic and cellular basis of dysfunction in psychosis and assess how these may affect patient variability in symptomatic expression and treatment response.
2. Describe changes in brain networks in psychosis and utilize this information to develop novel neuromodulation interventions.
3. Define the role of neuroinflammation to the pathophysiology of psychosis and apply it to the treatment of neuroinflammation in patients.
4. Identify risks for developing psychosis and assess the early signs of the disorder so that proper treatment modalities may be implemented.
Target Audience
Psychiatrists, Neuroscientists, Residents, and Clinicians
Directions
www.mountsinai.org/about-us/visiting-us
Accreditation
The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
The Icahn School of Medicine at Mount Sinai designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Policy
It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.
Special Needs
The Icahn School of Medicine at Mount Sinai is in full compliance with provisions of the Americans with Disabilities Act (ADA) and is accessible for individuals with special needs. If you would like to attend this conference and require any special needs or accommodations, please contact the Office of CME at 212-731-7950.
For Conference Information
Please e-mail the Office of CME at cme@mssm.edu or call 212-731-7950 .
——————————————————————————–
Visit us online at www.mssm.edu/psychiatry
Icahn School of Medicine at Mount Sinai
Department of Psychiatry
One Gustave Levy Place – Box 1230
New York, NY 10029
Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1193, New York, NY 10029
SafeUnsubscribe™ ahronfriedberg@gmail.com
Forward this email | Update Profile | About our service provider
Sent by cme@mssm.edu
=